May 17, 2011 – iCAD, an industry-leading provider of advanced image analysis, workflow solutions and radiation therapies for the early identification and treatment of cancer, announces that it has secured regulatory approval for its SecondLook Digital by the State Food and Drug Administration (SFDA) in the People’s Republic of China. The approval allows iCAD’s SecondLook Digital computer-aided detection (CAD) technology to be sold with GE Digital Mammography Systems in order to assist radiologists in distinguishing potential cancers from other anomalies on a mammogram.

May 16, 2011— GE Healthcare today received the Price Performance Value Leadership Award in PET (Positron Emission Tomography) for North America 2011 from global research organization Frost & Sullivan.

May 11, 2011 -The American Society of Echocardiography (ASE) will host its 22nd Annual Scientific Sessions: The Patient the Image: The Role of Cardiovascular Ultrasound in Clinical Decision Making (ASE 2011), June 11-14 at the Palais des Congres de Montreal in Montreal, Quebec, Canada.

May 10, 2011 – The Methodist Hospital in Houston has taken a significant new step in radiation therapy and surgical planning at the facility’s world renowned Plato’s CAVE (Computerized Augmented Visual Environment). New PhyZiodynamics from Ziosoft, Inc., a pioneer and leader in supercomputing functional analytics, will be used to produce true-fidelity, highly accurate 3-D and 4-D images based on computed tomography (CT), magnetic resonance (MR), and positron emission tomography (PET) scans of the brain, lungs and other organs.

May 10, 2011 – Hitachi announced it entered into an agreement to provide Mayo Clinic with its proton beam therapy (PBT) system. This next-generation technology has spot scanning capability for treating certain forms of cancer. The agreement includes PBT system maintenance for both facilities for 10 years following completion of the systems’ installation.

May 10, 2011 – Varian Medical Systems is highlighting its ProBeam proton therapy system and Eclipse treatment planning capabilities at the 2011 Particle Therapy Co-Operative Group (PTCOG) meeting from May 8-14 in Philadelphia.

May 6, 2011 – Nucletron will feature five new innovations at the ESTRO Anniversary Congress, May 8-11 in London, all designed to meet the growing interest and need to more effectively treat a wide variety of cancers. In addition Nucletron will be celebrating its long collaboration with ESTRO on its 30th anniversary.